Bence Daniel

23PUBLICATIONS
219CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsMolecular targetsInnate immunityGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 06, 2026
Promoter reinforcement supports transcriptional resilience in drug-resistant cancer.

|May 04, 2026
Phosphorylated ubiquitin is a secondary messenger and an epigenetic mark mediating mitochondria to nucleus signaling.

|Mar 31, 2026
Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER+ HER2- locally-advanced or metastatic breast cancer.

Jackson Liang, Christy Ong, Kareem Heslop

|Jan 14, 2026
A Double-Negative Prostate Cancer Subtype Is Vulnerable to SWI/SNF-Targeting Degrader Molecules.

Phillip Thienger, Irene Paassen, Xiaosai Yao

|Aug 08, 2025
Clonal lineage tracing of innate immune cells in human cancer.

Vincent Liu, Katalin Sandor, Patrick K Yan

|Aug 02, 2025
Epiregulon: Single-cell transcription factor activity inference to predict drug response and drivers of cell states.

Tomasz Włodarczyk, Aaron Lun, Diana Wu

Pageof 4

Frequent Collaborators

14 joint publications

Ansuman T Satpathy

9 joint publications

Katalin Sandor

5 joint publications

Caleb Lareau

5 joint publications

Julia Belk